Extension Study to Assess Batoclimab in Participants With Thyroid Eye Disease
Clinical trial NCT05517447 · TERMINATED
Trial details
- NCT number
- NCT05517447
- Sponsor
- Immunovant Sciences GmbH
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-06
- Primary completion
- 2026-04-02
- Enrollment
- 109
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.